Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria.

Hani Amir Aouissi Mostefa Ababsa Aissam Gaagai

Published in: Bulletin of the National Research Centre (2021)

We concluded that in brief, given the inexistence of a better solution, we ultimately recommend that patients with severe COVID-19 to be treated for the moment with Hydroxychloroquine combined with Azithromycin in view of its effectiveness, while waiting for another solution.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
systematic review
respiratory syndrome coronavirus
solid state
drug induced